What are the characteristic brain MRI findings of multiple sclerosis and how should they be evaluated and managed?

Characteristic Brain MRI Findings in Multiple Sclerosis

Multiple sclerosis brain lesions must demonstrate specific anatomical distribution patterns and morphological characteristics, with at least one typical MS lesion in at least two of four characteristic regions: periventricular (directly abutting lateral ventricles), juxtacortical/cortical, infratentorial, or spinal cord. 1

Key Diagnostic Lesion Characteristics

Lesion Size and Morphology

• Minimum size: Generally ≥3 mm in longest diameter, though smaller lesions (<3 mm) are acceptable in specific locations like the floor of the fourth ventricle, outer pons margin, or corpus callosum 2
• Shape: Ovoid lesions with long axis perpendicular to lateral ventricles (Dawson's fingers) 2
• Appearance: Focal T2/FLAIR hyperintensities, typically <1 cm diameter (though larger lesions can occur) 2
• Distribution: Asymmetric involvement of cerebral white matter 2

Four Critical Anatomical Locations

1. Periventricular Lesions

• Must be in direct contact with lateral ventricles without intervening normal white matter 2
• Include corpus callosum lesions that abut ventricles 2
• Exclude deep grey matter lesions (e.g., thalamus) even if they touch ventricles 2

2. Juxtacortical/Cortical Lesions

• Hallmark feature rarely seen in other conditions 2
• Affect U-fibers (typically spared in ischemia) 2
• Best visualized with 3D sequences: DIR, PSIR, or MPRAGE 2
• Pure cortical lesions without juxtacortical white matter involvement are difficult to detect on conventional MRI 2

3. Infratentorial Lesions

• Preferentially affect: floor of fourth ventricle, pons surface, intra-pontine trigeminal tracts, middle/superior cerebellar peduncles, periaqueductal grey matter, cerebellar white matter, medullary pyramids 2
• Typically peripheral in pons (versus central symmetric pontine lesions in small vessel disease) 1

4. Spinal Cord Lesions

• Cervical and thoracic involvement 1
• Required for comprehensive MS evaluation 1

Advanced Diagnostic Features

Central Vein Sign (CVS)

The CVS is present in most MS lesions and helps distinguish MS from mimickers 2

• Defined as thin (<2 mm diameter) hypointense line/dot running partially or entirely through lesion center 2
• Must be visible in two perpendicular planes 2
• Do not assess in lesions <3 mm, confluent lesions, or where veins are poorly visible 2
• Requires susceptibility-sensitive MRI sequences 2
• Rarely present in small vessel disease, AQP4+ NMOSD, or migraine 2

Gadolinium Enhancement Patterns

• Enhancement indicates active inflammation (dissemination in time) 2
• Typically transient: 2-8 weeks, usually 4 weeks 1
• Finding both enhancing and non-enhancing lesions on single scan demonstrates dissemination in time 2

Critical Pitfalls to Avoid

Non-Specific Lesions (Exclude from Diagnosis)

• Small (<3 mm), rounded, deep white matter lesions, especially in basal frontal areas without CVS 2
• Deep white matter lesions alone have low specificity and don't count for dissemination in space criteria (unless they enhance, show CVS, or have paramagnetic rim) 2

Age and Vascular Risk Factors

In patients >50 years or with vascular risk factors, require MORE STRINGENT criteria 1

• Demand higher number of periventricular lesions 1
• Deep white matter lesions should ideally be ovoid, involve corpus callosum/temporal lobe, show CVS, or have paramagnetic rim 2

Red Flags Suggesting Alternative Diagnoses

• Symmetric central pontine lesions (small vessel disease) 1
• Periaqueductal lesions (NMOSD) 1
• Persistent gadolinium enhancement >3 months 3
• Lesions with mass effect 3
• Meningeal enhancement 3

Essential MRI Protocol Requirements

Technical Standards

• Minimum field strength: 1.5T 1
• Slice thickness: 3D acquisitions or 2D with 3 mm slices, no gap 1
• Key sequences: T2-weighted, T2-FLAIR, T1 post-gadolinium for brain and spinal cord 1
• Multi-planar confirmation: Verify lesions on multiple planes to exclude artifacts 1

Comprehensive Imaging

• Brain MRI (mandatory) 1
• Cervical, thoracic, and lumbar spine MRI 1
• Fat-suppressed optic nerve MRI in atypical cases 1

Demonstrating Dissemination in Time

New T2 lesions on follow-up imaging at any time indicate dissemination in time 2

• New lesions don't need to be in characteristic anatomical locations 2
• Ensure new lesions aren't artifacts from protocol/positioning changes 2
• Alternatively, simultaneous enhancing and non-enhancing lesions on single scan suffice 2

Management Approach

Interpretation must be performed by trained neuroradiologists or clinicians deeply familiar with MS features and differential diagnoses 1. The 2024 MAGNIMS-CMSC-NAIMS consensus 2 represents the most current authoritative guidance, emphasizing that misinterpretation of MRI findings is the most common source of MS misdiagnosis 2.

Serial imaging supports diagnosis by demonstrating lesion accumulation over time in new CNS areas 1. For patients with few lesions, individual characteristics (size, ovoid shape, perpendicular orientation, T1 hypointensity, enhancement pattern) are critical; for those with many lesions, distribution pattern (periventricular predilection, brain-cord combinations) becomes more relevant 1.